Amy E. DeZern, MD, MHS - Small Words Make Large Differences: Best Practices in Supporting MDS Patients Across All Stages of Their Journey PeerVoice Oncology & Haematology Audio

Visit https://www.peervoice.com/BJP860 to view the entire programme with slides. After completing “Amy E. DeZern, MD, MHS - Small Words Make Large Differences: Best Practices in Supporting MDS Patients Across All Stages of Their Journey”, participants will be able to: Identify the data required to calculate a patient’s myelodysplastic syndrome (MDS) risk status by utilizing the Molecular International Prognostic Scoring System (IPSS-M); Identify patients with intermediate-risk MDS who may benefit from treatment for higher-risk MDS; Formulate initial treatment plans for high-risk MDS (HR-MDS) based on individual patient factors; and Identify opportunities to provide support to patients with HR-MDS beyond pharmacological management.